Inter-institutional initiative is similar to other efforts abroad to catalogue samples gathered from COVID-19 patients, but the quality of the data and samples, as well as the long-term focus of
The Institut national de santé publique du Québec (INSPQ) and the McGill Genome Centre partner to sequence SARS-CoV-2 genomes identified in Québec and better understand the disease The Institut national de
L’Institut national de santé publique du Québec se joint au Centre de génomique de l’Université McGill afin de séquencer les différentes souches virales des patients québécois atteints par la COVID-19.
https://www.tvanouvelles.ca/videos/6152200213001
Dr. Vincent Mooser is the first speaker in the CanCOVID speaker series. Dr. Mooser provides an update on the Covid-19 Quebec Biobank:
Q: «On dit que les gens du type O négatif sont plus résistants face à ce virus. Qu’en est-il vraiment?», demande Charles St-Amand. https://www.latribune.ca/actualites/vos-questions-sur-la-covid-19/le-groupe-sanguin-influe-t-il-sur-la-severite-de-la-covid-19-f9efccedd1146a79cb55bc575e72684f
World-class facility to take part in national effort to determine genetic sequence of 10,000 human sufferers of COVID-19 The McGill Genome Centre today announced it has received funding from the Canadian
CGEn will receive $20 million in Federal funding to sequence the genomes of thousands of Canadians, in order to better understand the variable clinical response to COVID-19. April 23, 2020
Resources for researchers and clinicians fighting COVID-19 in Canada COVID-19 Resources Canada is a central hub designed to help those involved in COVID-19 research and development in Canada to locate
Ils planchent sur des vaccins et des médicaments, utilisent l’intelligence artificielle pour accélérer les découvertes, cherchent à mieux comprendre le virus, son mode de propagation et les meilleures façons de